Cardiol therapeutics to present at td cowen 45th annual health care conference

Toronto, ontario--(newsfile corp. - march 3, 2025) - cardiol therapeutics inc. (nasdaq: crdl) (tsx: crdl) ("cardiol" or the "company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that it will present at the td cowen 45th annual health care conference in boston, ma, on march 5, 2025, at 11:10 a.m. est. a replay of the live webcast of the presentation will be available under "events & presentations" in the investors section of the cardiol website (www.cardiolrx.com/investors/events-presentations/).
COWN Ratings Summary
COWN Quant Ranking